SC 13D/A | 2021-02-16 | Morningside Venture (VI) Investments Ltd | CHINOOK THERAPEUTICS, INC. | 1,861,106 | 4.4% | EDGAR |
SC 13G/A | 2021-02-12 | Vivo Capital IX, LLC | CHINOOK THERAPEUTICS, INC. | 218,642 | 0.5% | EDGAR |
SC 13G/A | 2021-02-11 | RENAISSANCE TECHNOLOGIES LLC | CHINOOK THERAPEUTICS, INC. | 836,086 | 2.0% | EDGAR |
SC 13G | 2020-11-16 | Apple Tree Partners IV, L.P. | CHINOOK THERAPEUTICS, INC. | 4,028,937 | 9.6% | EDGAR |
SC 13G/A | 2020-11-09 | BlackRock Inc. | CHINOOK THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13D | 2020-10-15 | Versant Venture Capital VII, L.P. | ADURO BIOTECH, INC. | 4,733,023 | 11.2% | EDGAR |
SC 13G | 2020-06-11 | Vivo Capital IX, LLC | ADURO BIOTECH, INC. | 933,784 | 1.2% | EDGAR |
SC 13G | 2020-02-12 | RENAISSANCE TECHNOLOGIES LLC | ADURO BIOTECH, INC. | 4,638,310 | 5.8% | EDGAR |
SC 13G/A | 2020-02-05 | BlackRock Inc. | ADURO BIOTECH, INC. | 4,364,955 | 5.4% | EDGAR |
SC 13G | 2020-02-04 | BAILLIE GIFFORD & CO | ADURO BIOTECH, INC. | 4,232,256 | 5.3% | EDGAR |
SC 13G/A | 2020-01-17 | SINGER JAMES R | ADURO BIOTECH, INC. | 3,200,000 | 4.0% | EDGAR |
SC 13D/A | 2019-05-24 | Morningside Venture (VI) Investments Ltd | ADURO BIOTECH, INC. | 9,305,532 | 11.6% | EDGAR |
SC 13D/A | 2019-03-22 | Morningside Venture (VI) Investments Ltd | ADURO BIOTECH, INC. | 9,305,532 | 11.7% | EDGAR |
SC 13G/A | 2019-02-11 | WELLINGTON MANAGEMENT GROUP LLP | ADURO BIOTECH, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2019-02-08 | HARVARD MANAGEMENT CO INC | ADURO BIOTECH, INC. | 640,595 | 0.8% | EDGAR |
SC 13G | 2019-02-08 | BlackRock Inc. | ADURO BIOTECH, INC. | 5,324,644 | 6.7% | EDGAR |
SC 13G/A | 2019-01-22 | JOHNSON & JOHNSON | ADURO BIOTECH, INC. | 3,906,207 | 4.9% | EDGAR |
SC 13G/A | 2019-01-10 | WELLINGTON MANAGEMENT GROUP LLP | ADURO BIOTECH, INC. | 5,971,410 | 7.5% | EDGAR |
SC 13G/A | 2019-01-07 | SINGER JAMES R | ADURO BIOTECH, INC. | 4,258,000 | 5.4% | EDGAR |
SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | ADURO BIOTECH, INC. | 10,552,763 | 13.6% | EDGAR |